ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein 03 Jun 2022 A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer. Find out more Show/Hide
First clinical trial of innovative drug targeting HSF1 pathway begins 31 Dec 2021 The first cancer patients are to receive doses of an innovative new drug that targets a master regulatory pathway in cells, as part of a new clinical trial. Find out more Show/Hide
Researchers find immune system link with rare ovarian cancer that could guide future treatment 14 Oct 2021 Immune-related genes are associated with the development of the rare cancer ovarian clear cell carcinoma (OCCC), new research has found. Find out more Show/Hide
ESMO 2020: Step forward in treatment for patients with newly diagnosed advanced ovarian cancer 18 Sep 2020
MRI data can predict patient response to treatment and survival in advanced ovarian cancer 30 Jan 2020
ICR calls for wider gene testing in ovarian cancer after approval of olaparib earlier in treatment for women with BRCA mutations 26 Jul 2019